The lawsuit claims that labels on products such as Roundup’s Weed & Grass Killer falsely assured consumers that they target an enzyme not found “in people or pets.” However Roundup’s active ingredient glyphosate attacks an enzyme also found in the beneficial intestinal bacteria of humans and some animals. On March 12, 2020, plaintiffs filed a Consent Motion seeking preliminary approval of a class action settlement. The Court communicated some concerns to the parties, and, in response, the parties revised the settlement to provide: 1. Greater clarity with respect to the fact that personal injury claims were not released, 2. Specification of the amount of the incentive awards for the named Plaintiffs, 3. Specification of the cy pres recipients, and 4. Extensions to the deadlines for class members to submit claims and to opt out. On May 14, 2020, the Court preliminarily approved the settlement. A settlement fund of $39.55 million was created, and class members would receive 10% of the average retail price for each product (with a cap of one purchase per year if proof of purchase was lacking). Between May and September 2020, the parties employed additional notice measures not required by the Original Settlement. On Feb. 25, 2021 plaintiffs filed a consent motion for final approval of the settlement. On May 13, 2021, the Motion for Final Approval of Class Settlement is granted. The proposed class action Settlement will provide the Class with $39,550,000 of monetary relief to pay all aspects of the Settlement, including Class Members' claims, notice costs, administration costs, service awards of up to $2,500 to named plaintiffs, legal expenses, and attorneys' fees. On June 9, 2021, one objecting class member, Anna St. John, appeals to the US Court of Appeals for the 8th Circuit from the Order Granting Motion for Final Approval of Class Settlement and Award of Attorneys’ Fees.